Portage Biotech Analyst Ratings
BenzingaJan 8 13:36 ET
Analysts Offer Insights on Healthcare Companies: Harpoon Therapeutics (HARP), Portage Biotech Inc (PRTG) and Ambrx Biopharma (AMAM)
TipRanksJan 8 13:00 ET
HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $6
BenzingaNov 29, 2023 15:01 ET
Portage Biotech Analyst Ratings
BenzingaNov 29, 2023 15:00 ET
Portage Biotech Inc: A Buy Rating Amid Future Catalysts and Strategic Acquisitions
TipRanksNov 29, 2023 11:35 ET
Cantor Fitzgerald Reiterates Overweight on Portage Biotech, Maintains $11 Price Target
BenzingaSep 7, 2023 11:38 ET
Portage Biotech Analyst Ratings
BenzingaSep 7, 2023 11:37 ET
Cantor Fitzgerald Reiterates Overweight on Portage Biotech, Maintains $11 Price Target
BenzingaAug 31, 2023 09:23 ET
Portage Biotech Analyst Ratings
BenzingaAug 31, 2023 09:22 ET
Portage Biotech Inc (PRTG) Receives a Buy From H.C. Wainwright
TipRanksAug 2, 2023 06:25 ET
HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $9
BenzingaAug 2, 2023 06:23 ET
Portage Biotech Analyst Ratings
BenzingaAug 2, 2023 06:23 ET
Cantor Fitzgerald Maintains Overweight on Portage Biotech, Lowers Price Target to $11
BenzingaAug 1, 2023 09:26 ET
Portage Biotech Analyst Ratings
BenzingaAug 1, 2023 09:25 ET
HC Wainwright Adjusts Portage Biotech's Price Target to $21 From $22, Keeps Buy Rating
MT NewswiresDec 1, 2022 10:22 ET
Portage Biotech Analyst Ratings
Benzinga Analyst RatingsDec 1, 2022 06:18 ET
Oppenheimer Adjusts Portage Biotech Price Target to $18 From $26, Maintains Outperform Rating
MT NewswiresNov 30, 2022 08:56 ET
Portage Biotech Analyst Ratings
Benzinga Analyst RatingsNov 30, 2022 06:58 ET
Oppenheimer Maintains Outperform on Portage Biotech, Lowers Price Target to $18
Benzinga Real-time NewsNov 30, 2022 06:58 ET
Analysts Offer Insights on Healthcare Companies: Portage Biotech Inc (PRTG) and Virios Therapeutics (VIRI)
TipRanksSep 20, 2022 06:35 ET
No Data
No Data